🇺🇸 Sitagliptin combined with Beidougen capsule in United States

Sitagliptin combined with Beidougen capsule (Sitagliptin combined with Beidougen capsule) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Sitagliptin combined with Beidougen capsule in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Sitagliptin combined with Beidougen capsule approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sitagliptin combined with Beidougen capsule in United States?

Beijing Chao Yang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.